Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Irinotecan-gut microbiota interactions and the capability of probiotics to mitigate Irinotecan-associated toxicity
Marwa S. Mahdy, Ahmed F. Azmy, Tarek Dishisha, et al.
BMC Microbiology (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Dysbiosis–NK Cell Crosstalk in Pancreatic Cancer: Toward a Unified Biomarker Signature for Improved Clinical Outcomes
Sara Fanijavadi, Lars Henrik Jensen
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 730-730
Open Access | Times Cited: 1
Gut microbial β-glucuronidases influence endobiotic homeostasis and are modulated by diverse therapeutics
Joshua B. Simpson, Morgan E. Walker, Joshua J. Sekela, et al.
Cell Host & Microbe (2024) Vol. 32, Iss. 6, pp. 925-944.e10
Open Access | Times Cited: 12
The influence of microbiota on ferroptosis in intestinal diseases
Ting Yao, Lanjuan Li
Gut Microbes (2023) Vol. 15, Iss. 2
Open Access | Times Cited: 19
The Gum–Gut Axis: Periodontitis and the Risk of Gastrointestinal Cancers
Giacomo Baima, Davide Giuseppe Ribaldone, Federica Romano, et al.
Cancers (2023) Vol. 15, Iss. 18, pp. 4594-4594
Open Access | Times Cited: 18
Past, present, and future of microbiome-based therapies
Pilar Manrique, Ignacio Montero, Marta Fernandez-Gosende, et al.
Microbiome Research Reports (2024) Vol. 3, Iss. 2
Open Access | Times Cited: 5
Microbiome Integrity Enhances the Efficacy and Safety of Anticancer Drug
Alice Njolke Mafe, Dietrich Büsselberg
Biomedicines (2025) Vol. 13, Iss. 2, pp. 422-422
Open Access
The oncobiome; what, so what, now what?
Munawar Abbas, Mark Tangney
Microbiome Research Reports (2025) Vol. 4, Iss. 1
Open Access
The Impact of Microbiota on Neurological Disorders: Mechanisms and Therapeutic Implications
Giuseppe Merra, Giada La Placa, Marcello Covino, et al.
OBM Neurobiology (2025) Vol. 09, Iss. 01, pp. 1-12
Open Access
Managing Irinotecan-Induced Diarrhea: A Comprehensive Review of Therapeutic Interventions in Cancer Treatment
Xiaoqin Yang, Jiamei Chen, Yitao Wang, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 359-359
Open Access
Exploring the Impact of Chemotherapy on the Emergence of Antibiotic Resistance in the Gut Microbiota of Colorectal Cancer Patients
Mutebi John Kenneth, Chin‐Chia Wu, Chuan‐Yin Fang, et al.
Antibiotics (2025) Vol. 14, Iss. 3, pp. 264-264
Open Access
Cordyceps militaris extract and cordycepin ameliorate LPS-challenged colonic damage in piglets by modulating the microbiota and metabolite profiles
Shi‐Jie Xiong, Fan Wan, Jiajia Jiang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Unraveling the role of medicinal plants and Gut microbiota in colon cancer: Towards microbiota- based strategies for prevention and treatment
Arumugam Vignesh, Thomas Cheeran Amal, S. Selvakumar, et al.
Health Sciences Review (2023) Vol. 9, pp. 100115-100115
Open Access | Times Cited: 14
Updated perspectives on the contribution of the microbiome to the pathogenesis of mucositis using the MASCC/ISOO framework
Andrea M. Stringer, Benjamin M. Hargreaves, Rui Amaral Mendes, et al.
Supportive Care in Cancer (2024) Vol. 32, Iss. 8
Open Access | Times Cited: 3
Microbial metabolism marvels: a comprehensive review of microbial drug transformation capabilities
F. Martinelli, Ines Thiele
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 3
Ginsenoside Rh4 alleviates gastrointestinal mucositis and enhances chemotherapy efficacy through modulating gut microbiota
Xue Bai, Jianjun Deng, Zhiguang Duan, et al.
Phytomedicine (2024) Vol. 128, pp. 155577-155577
Closed Access | Times Cited: 2
Discovery of a botanical compound as a broad-spectrum inhibitor against gut microbial β-glucuronidases from the Tibetan medicine Rhodiola crenulata
Lü Chen, Xudong Hou, Guanghao Zhu, et al.
International Journal of Biological Macromolecules (2024) Vol. 267, pp. 131150-131150
Closed Access | Times Cited: 2
Gut Microbiota—Adversary or Ally? Its Role and Significance in Colorectal Cancer Pathogenesis, Progression, and Treatment
Katarzyna Chawrylak, Magdalena Leśniewska, Katarzyna Mielniczek, et al.
Cancers (2024) Vol. 16, Iss. 12, pp. 2236-2236
Open Access | Times Cited: 2
Three bioactive compounds from Huangqin decoction ameliorate Irinotecan-induced diarrhea via dual-targeting of Escherichia coli and bacterial β-glucuronidase
Xiaojun Teng, Bingxin Wu, Zuhui Liang, et al.
Cell Biology and Toxicology (2024) Vol. 40, Iss. 1
Open Access | Times Cited: 2
Gut microbiota in cancer: insights on microbial metabolites and therapeutic strategies
Yalan Chen, Xibin Wang, Yuwei Ye, et al.
Medical Oncology (2023) Vol. 41, Iss. 1
Closed Access | Times Cited: 7
Treatment with S-adenosylmethionine ameliorates irinotecan-induced intestinal barrier dysfunction and intestinal microbial disorder in mice
Lin Xiao, Weidong Dou, Yajie Wang, et al.
Biochemical Pharmacology (2023) Vol. 216, pp. 115752-115752
Open Access | Times Cited: 5
In Vitro Influence of Specific Bacteroidales Strains on Gut and Liver Health Related to Metabolic Dysfunction-Associated Fatty Liver Disease
Diego García-Morena, María Victoria Fernández-Cantos, Silvia Lopez-Escalera, et al.
Probiotics and Antimicrobial Proteins (2024)
Open Access | Times Cited: 1
A concise review of the impact of groundwater pollution in coastal regions on human gut microbiome composition and its effect on human health
A T Rithi, Antara Banerjee, Abhijit Mitra, et al.
Groundwater for Sustainable Development (2024) Vol. 26, pp. 101187-101187
Closed Access | Times Cited: 1
Interplay between WNT/PI3K-mTOR axis and the microbiota in APC-driven colorectal carcinogenesis: data from a pilot study and possible implications for CRC prevention
Floriana Jessica Di Paola, Chiara Alquati, Gabriele Conti, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
From microbes to medicine: harnessing the power of the microbiome in esophageal cancer
Xiaoyan Liu, Bang Li, Liping Liang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Emerging Role of Gut Microbiota in Breast Cancer Development and Its Implications in Treatment
Rashid Mir, Shrooq A. Albarqi, Wed Albalawi, et al.
Metabolites (2024) Vol. 14, Iss. 12, pp. 683-683
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top